MedPath

NMPA Approvals

Chinese National Medical Products Administration approved drug approval numbers and registration information

National Medical Products Administration
China
166,322 Approvals
Showing 2081 to 2100 of 166,322 approvalsPage 105 of 8317

Empagliflozin Tablets

Approval Number: 国药准字H20249836
Registration: Dec 25, 2024
惠升生物制药股份有限公司

Phenylephrine Hydrochloride Injection

Approval Number: 国药准字H20249841
Registration: Dec 25, 2024
海南倍特药业有限公司

Glucosamine Sulfate Capsules

Approval Number: 国药准字H20249797
Registration: Dec 25, 2024
山西辅仁恒峰药业有限公司

Aminophylline Injection

Approval Number: 国药准字H20249813
Registration: Dec 25, 2024
江西人可医药科技有限公司

Propranolol Hydrochloride Injection

Approval Number: 国药准字H20249769
Registration: Dec 25, 2024
华夏生生药业（北京）有限公司

Omeprazole and Sodium Bicarbonate Capsules

Approval Number: 国药准字H20249803
Registration: Dec 25, 2024
海南广升誉制药有限公司

Lercanidipine Hydrochloride Tablets

Approval Number: 国药准字H20249816
Registration: Dec 25, 2024
杭州沐源生物医药科技有限公司

Dapagliflozin Tablets

Approval Number: 国药准字H20249826
Registration: Dec 25, 2024
湖南九典制药股份有限公司

Tadalafil Tablets

Approval Number: 国药准字H20249799
Registration: Dec 25, 2024
广东泉新泉益药业有限公司

Phenylephrine Hydrochloride Injection

Approval Number: 国药准字H20249840
Registration: Dec 25, 2024
海南倍特药业有限公司

Piracetam Injection

Approval Number: 国药准字H20249777
Registration: Dec 25, 2024
福建省闽东力捷迅药业股份有限公司

Ibuprofen Concentrated Solution for Injection

Approval Number: 国药准字H20249806
Registration: Dec 25, 2024
海南合瑞制药股份有限公司

Tadalafil Tablets

Approval Number: 国药准字H20249800
Registration: Dec 25, 2024
广东泉新泉益药业有限公司

Ambroxol Hydrochloride Oral Solution

Approval Number: 国药准字H20249794
Registration: Dec 25, 2024
安徽海斯美医药有限公司

Iopromide Injection

Approval Number: 国药准字H20249781
Registration: Dec 25, 2024
四川科伦药业股份有限公司

Bendamustine Hydrochloride for Injection

Approval Number: 国药准字H20249779
Registration: Dec 25, 2024
南京力成药业有限公司

Bisoprolol Fumarate and Amlodipine Besilate Tablets

Approval Number: 国药准字H20249788
Registration: Dec 25, 2024
安徽博诺美科生物医药有限公司

Bendamustine Hydrochloride for Injection

Approval Number: 国药准字H20249778
Registration: Dec 25, 2024
南京力成药业有限公司

Cefaclor for Suspension

Approval Number: 国药准字H20249785
Registration: Dec 25, 2024
海南海药股份有限公司海口市制药厂

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.